Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Triple Therapy (Lonafarnib, Pravastatin, Zoledronic Acid) for Progeria
NCT00879034Phase 2Completed
- Sponsor
- Boston Children's Hospital
- Start
- Mar 2009
- Primary completion
- Apr 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of lonafarnib in Hutchinson-Gilford progeria syndrome (HGPS), progeroid laminopathy, sponsored by Boston Children's Hospital. Started Mar 2009; status: completed.
02
Drugs
lonafarnib
03
Conditions
Hutchinson-Gilford progeria syndrome (HGPS)progeroid laminopathy
Beyond the preview
Go deeper on NCT00879034.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00879034.